VANGUARD GROUP INC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,087,941
-58.9%
1,220,530
+8.1%
0.00%
Q2 2023$7,517,288
-62.1%
1,128,722
+6.1%
0.00%
-100.0%
Q1 2023$19,853,756
-11.5%
1,063,974
+1.9%
0.00%0.0%
Q4 2022$22,429,501
+84.2%
1,044,204
+1.4%
0.00%
Q3 2022$12,177,000
-7.3%
1,030,171
+3.5%
0.00%
Q2 2022$13,141,000
-40.7%
995,538
-6.0%
0.00%
-100.0%
Q1 2022$22,155,000
+6.6%
1,059,535
+3.6%
0.00%
Q4 2021$20,784,000
-29.2%
1,022,331
+5.6%
0.00%
-100.0%
Q3 2021$29,376,000
+12.0%
967,920
+7.2%
0.00%0.0%
Q2 2021$26,231,000
-23.0%
902,646
+14.3%
0.00%0.0%
Q1 2021$34,071,000
-18.9%
789,439
-13.1%
0.00%0.0%
Q4 2020$41,986,000
+11.2%
908,784
+4.3%
0.00%0.0%
Q3 2020$37,772,000
+23.6%
871,138
+51.1%
0.00%0.0%
Q2 2020$30,564,000
+178.8%
576,588
+17.5%
0.00%
Q1 2020$10,964,000
+93.6%
490,569
+26.6%
0.00%
Q4 2019$5,663,000
+110.0%
387,624
+1.2%
0.00%
Q3 2019$2,697,000
-5.1%
383,065
+47.7%
0.00%
Q2 2019$2,842,000
+61.1%
259,301
+45.4%
0.00%
Q1 2019$1,764,000
+687.5%
178,342
+206.1%
0.00%
Q4 2018$224,000
-90.1%
58,257
-80.3%
0.00%
Q3 2018$2,269,000
-18.0%
296,233
-1.5%
0.00%
Q2 2018$2,767,000
-8.4%
300,798
+2.0%
0.00%
Q1 2018$3,020,000295,0000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders